Zacks Research Cuts Earnings Estimates for Elevance Health
Stock analysts at Zacks Research dropped their Q1 2025 EPS estimates for Elevance Health in a note issued to investors on Thursday, January 30th. Zacks Research analyst K. Dey now forecasts that the ...
Hosted on MSN3d
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates
Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non ...
AbbVie Q4 Earnings: Good 2025 Outlook Despite Enhanced Old And New Headwinds
AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...
Elevance Health: Trading At Depressed Levels, So We Added Modestly
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...
Elevance Health Inc. stock underperforms Wednesday when compared to competitors
Shares of Elevance Health Inc. ELV shed 1.26% to $400.30 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.47% to 6,039.31 ...
Hosted on MSN5d
Can Centene's Q4 Earnings Navigate Through Rising Medical Costs?
Healthcare plan provider Centene Corporation CNC is set to report fourth-quarter 2024 results on Feb. 4, 2025, before the ...
A Glimpse Into The Expert Outlook On Elevance Health Through 6 Analysts
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...